OMAD

Daily intermittent fasting in healthy humans reduced hunger hormones, blood pressure, oxidative stress, and improved circadian rhythms and aging biomarkers.

Small trial of evening one-meal eating in healthy subjects aided weight loss through calorie reduction, with limited evidence beyond metabolic effects.

Review of intermittent fasting regimens including ADF and TRF in healthy humans found no clear short-term cognitive benefits, but noted improvements in metabolic markers like reduced blood lipids and heart rate after prolonged ADF.

Alternate-day fasting in healthy adults led to 2.5-8% weight loss over 8-12 weeks, with improvements in glucose, insulin, and some lipid profiles, alongside minimal adverse effects on mood.

Daily intermittent fasting in healthy humans reduced hunger hormones, blood pressure, oxidative stress, and improved circadian rhythms and aging biomarkers.

Alternate-day fasting in healthy adults led to 2.5-8% weight loss over 8-12 weeks, with improvements in glucose, insulin, and some lipid profiles, alongside minimal adverse effects on mood.

Daily intermittent fasting in healthy humans reduced hunger hormones, blood pressure, oxidative stress, and improved circadian rhythms and aging biomarkers.

Alternate-day fasting in healthy adults led to 2.5-8% weight loss over 8-12 weeks, with improvements in glucose, insulin, and some lipid profiles, alongside minimal adverse effects on mood.

Small trial of evening one-meal eating in healthy subjects aided weight loss through calorie reduction, with limited evidence beyond metabolic effects.

Review of intermittent fasting regimens including ADF and TRF in healthy humans found no clear short-term cognitive benefits, but noted improvements in metabolic markers like reduced blood lipids and heart rate after prolonged ADF.

Small trial of evening one-meal eating in healthy subjects aided weight loss through calorie reduction, with limited evidence beyond metabolic effects.